| A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV M Yuan, NC Wu, X Zhu, CCD Lee, RTY So, H Lv, CKP Mok, IA Wilson Science 368 (6491), 630-633, 2020 | 1567 | 2020 |
| Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans PS Arunachalam, F Wimmers, CKP Mok, RAPM Perera, M Scott, T Hagan, ... Science 369 (6508), 1210-1220, 2020 | 1097 | 2020 |
| Kinetics of viral load and antibody response in relation to COVID-19 severity Y Wang, L Zhang, L Sang, F Ye, S Ruan, B Zhong, T Song, AN Alshukairi, ... The Journal of clinical investigation 130 (10), 5235-5244, 2020 | 603 | 2020 |
| Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections H Lv, NC Wu, OTY Tsang, M Yuan, RAPM Perera, WS Leung, RTY So, ... Cell reports 31 (9), 2020 | 451 | 2020 |
| Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020 RAPM Perera, CKP Mok, OTY Tsang, H Lv, RLW Ko, NC Wu, M Yuan, ... Eurosurveillance 25 (16), 2000421, 2020 | 383 | 2020 |
| Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA. 1 following homologous and heterologous CoronaVac or BNT162b2 vaccination SMS Cheng, CKP Mok, YWY Leung, SS Ng, KCK Chan, FW Ko, C Chen, ... Nature medicine 28 (3), 486-489, 2022 | 363 | 2022 |
| ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection A Hachim, N Kavian, CA Cohen, AWH Chin, DKW Chu, CKP Mok, ... Nature immunology 21 (10), 1293-1301, 2020 | 279* | 2020 |
| Human infection with a novel avian influenza A (H5N6) virus ZF Yang, CKP Mok, JSM Peiris, NS Zhong New England Journal of Medicine 373 (5), 487-489, 2015 | 193 | 2015 |
| p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1 DCW Lee, CY Cheung, AHY Law, CKP Mok, M Peiris, ASY Lau Journal of virology 79 (16), 10147-10154, 2005 | 177 | 2005 |
| Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts CKP Mok, HHY Lee, M Lestra, JM Nicholls, MCW Chan, SF Sia, H Zhu, ... Journal of virology 88 (6), 3568-3576, 2014 | 172 | 2014 |
| Human infection with highly pathogenic avian influenza A (H7N9) virus, China C Ke, CKP Mok, W Zhu, H Zhou, J He, W Guan, J Wu, W Song, D Wang, ... Emerging infectious diseases 23 (8), 1332, 2017 | 168 | 2017 |
| Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong CKP Mok, CA Cohen, SMS Cheng, C Chen, KO Kwok, K Yiu, TO Chan, ... Respirology, 2021 | 155 | 2021 |
| Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients Y Wang, D Wang, L Zhang, W Sun, Z Zhang, W Chen, A Zhu, Y Huang, ... Genome Medicine 13, 1-13, 2021 | 118 | 2021 |
| Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events SC Ng, Y Peng, L Zhang, CKP Mok, S Zhao, A Li, JYL Ching, Y Liu, S Yan, ... Gut 71 (6), 1106-1116, 2022 | 112 | 2022 |
| Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract MCW Chan, RWY Chan, LLY Chan, CKP Mok, KPY Hui, JHM Fong, ... The Lancet Respiratory Medicine 1 (7), 534-542, 2013 | 110 | 2013 |
| Differential onset of apoptosis in influenza A virus H5N1-and H1N1-infected human blood macrophages CKP Mok, DCW Lee, CY Cheung, M Peiris, ASY Lau Journal of general virology 88 (4), 1275-1280, 2007 | 103 | 2007 |
| Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection D Munnur, Q Teo, D Eggermont, HHY Lee, F Thery, J Ho, SW van Leur, ... Nature immunology 22 (11), 1416-1427, 2021 | 96 | 2021 |
| Amino acid residues 253 and 591 of the PB2 protein of avian influenza virus A H9N2 contribute to mammalian pathogenesis CKP Mok, HL Yen, MYM Yu, KM Yuen, SF Sia, MCW Chan, G Qin, WW Tu, ... Journal of virology 85 (18), 9641-9645, 2011 | 87 | 2011 |
| Simeprevir potently suppresses SARS-CoV-2 replication and synergizes with remdesivir HS Lo, KPY Hui, HM Lai, X He, KS Khan, S Kaur, J Huang, Z Li, ... ACS central science 7 (5), 792-802, 2021 | 84 | 2021 |
| Pathogenicity of the novel A/H7N9 influenza virus in mice CKP Mok, HHY Lee, MCW Chan, SF Sia, M Lestra, JM Nicholls, H Zhu, ... MBio 4 (4), 10.1128/mbio. 00362-13, 2013 | 78* | 2013 |
Nicholas C. WuUniversity of Illinois at Urbana-Champaign在 illinois.edu 的电子邮件经过验证
